Clovis Oncology, Inc. (NASDAQ:CLVS) announced today after opposition proceedings at The Hague, Netherlands, that the European Patent Office upheld claims
Immutep has been granted a number of patents in Europe for its lead cancer drug candidate Biotechnology company Immutep (ASX: IMM) has
More effective delivery of drugs than drops for treating glaucoma, dry eye and for post-operative eye care OcuMedic, Inc., the
BioArctic AB announced today that the European Patent Office (EPO) has issued a decision to grant the company’s patent application
Scapa Healthcare, a global strategic outsource partner of skin friendly turn-key solutions, has been granted a European patent for a
Cleantech industrial oil refining company, Hydrodec Group, said it had been granted a patent in Europe for its refining technology.
GlycoMimetics Receives Japanese Patent For Uproleselan (GMI-1271) Issued patent expands global patent portfolio for GlycoMimetics’ late-stage drug candidate targeting treatment